Risk of thiazide-induced metabolic adverse events in older adults

Anil N. Makam, W. John Boscardin, Yinghui Miao, Michael A. Steinman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives To evaluate the risk and predictors of thiazide-induced adverse events (AEs) in multimorbid older adults in real-world clinical settings. Design Observational cohort study. Setting National Veterans Affairs data from 2007 to 2008. Participants Veterans aged 65 and older newly prescribed a thiazide (N = 1,060) compared with propensity-matched nonusers of antihypertensive medications (N = 1,060). Measurements The primary outcome was a composite of metabolic AEs defined as sodium less than 135 mEq/L, potassium less than 3.5 mEq/L, or a decrease in the estimated glomerular filtration rate (eGFR) of more than 25% from the baseline rate. Secondary outcomes included sev-ere AEs (sodium <130 mEq/L, potassium <3.0 mEq/L, or a decrease in eGFR of more than 50%). Results Over 9 months of follow-up, 14.3% of new thiazide users developed an AE, compared with 6.0% of nonusers (number needed to harm (NNH) 12, 95% confidence interval (CI) = 9-17, P <.001); 1.8% of new users developed a severe AE, compared with 0.6% of nonusers (NNH = 82, P =.008), and 3.8% of new users had an emergency department visit or hospitalization with an AE, compared with 2.0% of nonusers (NNH = 56, P =.02). Risk of AEs did not vary according to age, but having five or more comorbidities was associated with 3.0 times the odds (95% CI = 1.4-6.2) of developing an AE as having one comorbidity (hypertension). Low-normal and unmeasured baseline sodium and potassium values were among the strongest predictors of hyponatremia and hypokalemia, respectively. Only 42% of thiazide users had laboratory monitoring within 90 days after initiation. Conclusion Thiazide-induced AEs are common in older adults. Greater attention should be paid to potential complications in prescribing thiazides to older adults, including closer laboratory monitoring before and after initiation of thiazides.

Original languageEnglish (US)
Pages (from-to)1039-1045
Number of pages7
JournalJournal of the American Geriatrics Society
Volume62
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Thiazides
Potassium
Sodium
Veterans
Glomerular Filtration Rate
Comorbidity
Confidence Intervals
Hypokalemia
Hyponatremia
Antihypertensive Agents
Observational Studies
Hospital Emergency Service
Hospitalization
Cohort Studies
Hypertension

Keywords

  • aged adverse effects
  • hypertension
  • outcome assessment (health care)
  • sodium chloride symporter inhibitors

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Risk of thiazide-induced metabolic adverse events in older adults. / Makam, Anil N.; John Boscardin, W.; Miao, Yinghui; Steinman, Michael A.

In: Journal of the American Geriatrics Society, Vol. 62, No. 6, 2014, p. 1039-1045.

Research output: Contribution to journalArticle

Makam, Anil N. ; John Boscardin, W. ; Miao, Yinghui ; Steinman, Michael A. / Risk of thiazide-induced metabolic adverse events in older adults. In: Journal of the American Geriatrics Society. 2014 ; Vol. 62, No. 6. pp. 1039-1045.
@article{c4b4b4bfa2ef4864a29f743484f5d70e,
title = "Risk of thiazide-induced metabolic adverse events in older adults",
abstract = "Objectives To evaluate the risk and predictors of thiazide-induced adverse events (AEs) in multimorbid older adults in real-world clinical settings. Design Observational cohort study. Setting National Veterans Affairs data from 2007 to 2008. Participants Veterans aged 65 and older newly prescribed a thiazide (N = 1,060) compared with propensity-matched nonusers of antihypertensive medications (N = 1,060). Measurements The primary outcome was a composite of metabolic AEs defined as sodium less than 135 mEq/L, potassium less than 3.5 mEq/L, or a decrease in the estimated glomerular filtration rate (eGFR) of more than 25{\%} from the baseline rate. Secondary outcomes included sev-ere AEs (sodium <130 mEq/L, potassium <3.0 mEq/L, or a decrease in eGFR of more than 50{\%}). Results Over 9 months of follow-up, 14.3{\%} of new thiazide users developed an AE, compared with 6.0{\%} of nonusers (number needed to harm (NNH) 12, 95{\%} confidence interval (CI) = 9-17, P <.001); 1.8{\%} of new users developed a severe AE, compared with 0.6{\%} of nonusers (NNH = 82, P =.008), and 3.8{\%} of new users had an emergency department visit or hospitalization with an AE, compared with 2.0{\%} of nonusers (NNH = 56, P =.02). Risk of AEs did not vary according to age, but having five or more comorbidities was associated with 3.0 times the odds (95{\%} CI = 1.4-6.2) of developing an AE as having one comorbidity (hypertension). Low-normal and unmeasured baseline sodium and potassium values were among the strongest predictors of hyponatremia and hypokalemia, respectively. Only 42{\%} of thiazide users had laboratory monitoring within 90 days after initiation. Conclusion Thiazide-induced AEs are common in older adults. Greater attention should be paid to potential complications in prescribing thiazides to older adults, including closer laboratory monitoring before and after initiation of thiazides.",
keywords = "aged adverse effects, hypertension, outcome assessment (health care), sodium chloride symporter inhibitors",
author = "Makam, {Anil N.} and {John Boscardin}, W. and Yinghui Miao and Steinman, {Michael A.}",
year = "2014",
doi = "10.1111/jgs.12839",
language = "English (US)",
volume = "62",
pages = "1039--1045",
journal = "Journal of the American Geriatrics Society",
issn = "0002-8614",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Risk of thiazide-induced metabolic adverse events in older adults

AU - Makam, Anil N.

AU - John Boscardin, W.

AU - Miao, Yinghui

AU - Steinman, Michael A.

PY - 2014

Y1 - 2014

N2 - Objectives To evaluate the risk and predictors of thiazide-induced adverse events (AEs) in multimorbid older adults in real-world clinical settings. Design Observational cohort study. Setting National Veterans Affairs data from 2007 to 2008. Participants Veterans aged 65 and older newly prescribed a thiazide (N = 1,060) compared with propensity-matched nonusers of antihypertensive medications (N = 1,060). Measurements The primary outcome was a composite of metabolic AEs defined as sodium less than 135 mEq/L, potassium less than 3.5 mEq/L, or a decrease in the estimated glomerular filtration rate (eGFR) of more than 25% from the baseline rate. Secondary outcomes included sev-ere AEs (sodium <130 mEq/L, potassium <3.0 mEq/L, or a decrease in eGFR of more than 50%). Results Over 9 months of follow-up, 14.3% of new thiazide users developed an AE, compared with 6.0% of nonusers (number needed to harm (NNH) 12, 95% confidence interval (CI) = 9-17, P <.001); 1.8% of new users developed a severe AE, compared with 0.6% of nonusers (NNH = 82, P =.008), and 3.8% of new users had an emergency department visit or hospitalization with an AE, compared with 2.0% of nonusers (NNH = 56, P =.02). Risk of AEs did not vary according to age, but having five or more comorbidities was associated with 3.0 times the odds (95% CI = 1.4-6.2) of developing an AE as having one comorbidity (hypertension). Low-normal and unmeasured baseline sodium and potassium values were among the strongest predictors of hyponatremia and hypokalemia, respectively. Only 42% of thiazide users had laboratory monitoring within 90 days after initiation. Conclusion Thiazide-induced AEs are common in older adults. Greater attention should be paid to potential complications in prescribing thiazides to older adults, including closer laboratory monitoring before and after initiation of thiazides.

AB - Objectives To evaluate the risk and predictors of thiazide-induced adverse events (AEs) in multimorbid older adults in real-world clinical settings. Design Observational cohort study. Setting National Veterans Affairs data from 2007 to 2008. Participants Veterans aged 65 and older newly prescribed a thiazide (N = 1,060) compared with propensity-matched nonusers of antihypertensive medications (N = 1,060). Measurements The primary outcome was a composite of metabolic AEs defined as sodium less than 135 mEq/L, potassium less than 3.5 mEq/L, or a decrease in the estimated glomerular filtration rate (eGFR) of more than 25% from the baseline rate. Secondary outcomes included sev-ere AEs (sodium <130 mEq/L, potassium <3.0 mEq/L, or a decrease in eGFR of more than 50%). Results Over 9 months of follow-up, 14.3% of new thiazide users developed an AE, compared with 6.0% of nonusers (number needed to harm (NNH) 12, 95% confidence interval (CI) = 9-17, P <.001); 1.8% of new users developed a severe AE, compared with 0.6% of nonusers (NNH = 82, P =.008), and 3.8% of new users had an emergency department visit or hospitalization with an AE, compared with 2.0% of nonusers (NNH = 56, P =.02). Risk of AEs did not vary according to age, but having five or more comorbidities was associated with 3.0 times the odds (95% CI = 1.4-6.2) of developing an AE as having one comorbidity (hypertension). Low-normal and unmeasured baseline sodium and potassium values were among the strongest predictors of hyponatremia and hypokalemia, respectively. Only 42% of thiazide users had laboratory monitoring within 90 days after initiation. Conclusion Thiazide-induced AEs are common in older adults. Greater attention should be paid to potential complications in prescribing thiazides to older adults, including closer laboratory monitoring before and after initiation of thiazides.

KW - aged adverse effects

KW - hypertension

KW - outcome assessment (health care)

KW - sodium chloride symporter inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84902355103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902355103&partnerID=8YFLogxK

U2 - 10.1111/jgs.12839

DO - 10.1111/jgs.12839

M3 - Article

VL - 62

SP - 1039

EP - 1045

JO - Journal of the American Geriatrics Society

JF - Journal of the American Geriatrics Society

SN - 0002-8614

IS - 6

ER -